• BioHarvest Sciences Inc. (BHSC) appoints Gavriel Lambert to the Board of Advisors
  • Gavriel brings 27 years of experience in global investment banking
  • As of May 22, Gavriel has been Head of Consumer Retail Group, EMEA, and Co-Head of Global Retail for Jefferies Group
  • Before joining Barclays in 2013, his extensive career (that started in 1995) included holding senior investment banking positions at Solomon Smith Barney, J.P. Morgan and more
  • BioHarvest Sciences Inc. (BHSC) is down over 2 per cent, trading at C$0.24 at 11:31 am EST

BioHarvest Sciences (BHSC) has appointed Gavriel Lambert to serve on its Board of Advisors.

Gavriel brings 27 years of experience in global investment banking and will complement BioHarvest’s Board of Advisors.

Ilan Sobel, CEO of BioHarvest, remarked on Gavriel’s appointment.

“Gavriel’s extensive experience in banking comes at an important junction of the company’s evolution as it seeks new partnerships with the several US and international entities that would accelerate the market reach of BHSC’s products and technology.”

Gavriel Lambert looks forward to his new role and what it will bring.

“I strongly believe in the power of the Bio-Plant CELLicitation™ technology that BioHarvest brought to the world.”

“This proprietary technology is set to make a significant impact in the life science-based businesses and as such is attractive to a large array of US and international companies covering multiple multi-billion dollars’ verticals including Cannabis, Food, Nutraceuticals, Biotech and Pharm,” added Lambert.

As of May 22, Gavriel has been Head of Consumer Retail Group, EMEA (Europe, Middle East and Africa) and Co-Head of Global Retail for Jefferies Group.

Before this new appointment and from 2016, Gavriel headed the EMEA Consumer Retail Group for Barclays Plc.

He has been involved in several dozens of significant M&A and financing transactions.

Before joining Barclays in 2013, his extensive career (that started in 1995) included holding senior investment banking positions at Solomon Smith Barney, J.P. Morgan and UBS Securities.

Gavriel holds a Master’s degree (MBA) in finance from the Columbia Business School and a BSc Honors in Psychology from the London School of Economics.

BioHarvest Sciences bio-cell growth platform technology grows active and beneficial ingredients in fruit and plants, at an industrial scale, without increasing the plant size itself.

BioHarvest Sciences Inc. (BHSC) is down over 2 per cent, trading at C$0.24 at 11:31 am EST.

More From The Market Online

Tilray’s Breckenridge Brewery honours Denver Nuggets with new ale

Tilray Brands (TSX:TLRY) subsidiary Breckenridge Brewery launches a new ale to recognize the 2023 NBA championship-winning Denver Nuggets.

Avicanna launches 10% CBD (THC free) formula in Canada

Avicanna (TSX:AVCN) launches RHO Phyto Micro Drop 100, a 10 per cent CBD (THC free), proprietary oral formulation in Canada.

Organigram looks to raise capital as cannabis stocks surge

Organigram (TSX:OGI), one of Canada's first cannabis stocks, announces an overnight marketed public offering of units for up to C$25 million.